-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Save the date! RegMed XB 2nd Annual Conference
Save the Date! Join us for an exciting community event on June 12th and 13th, covering the entire spectrum of regenerative medicine, from cutting-edge research to practical solutions.
read more
De tijd van Marianne van der Steen bij RegMed XB
RegMed XB: het is in 2016 dat Clemens van Blitterswijk samen met Marianne van der Steen, Tom Oostrom en anderen begon aan een ambitieuze reis om een translationeel instituut te creëren dat zich richt op baanbrekende projecten in regeneratieve geneeskunde.
read more
Insights from the EU-Japan Biotech & Pharma Partnering Conference 2023
Representatives of RegMed XB and the RegMed XB Pilot Factory recently traveled to Japan to visit several prime regenerative medicine centers such as CIRA in Kyoto and Osaka University and participate in the EU-Japan Biotech & Pharma Partnering Conference 2023 in Osaka and Bio Japan in Yokohama.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
